Cancer patients continue to face more risk from COVID-19, even if they’ve been vaccinated. Although vaccination is effective for most people who have cancer (even though they’re immunocompromised by the disease and their cancer treatments), its effectiveness wanes more rapidly in this group, by three to six months compared to the general population, new research…  read on >  read on >

If you’re poor and have a severe type of heart attack, the chance you’ll live through it is significantly lower than that of someone with more money, new research shows. The finding underscores the need to close a divide in health care that hits low-income people hard, said lead researcher Dr. Abdul Mannan Khan Minhas,…  read on >  read on >

COVID-19 might be easing into a new status as a widely circulating and somewhat harsher version of the common cold, experts say — a virus that folks could contract repeatedly, even if they were recently infected. “[SARS-CoV-2] is destined to join four of its family members and become an endemic coronavirus that will repeatedly infect…  read on >  read on >

Americans with sickle cell disease who have private insurance face average out-of-pocket costs of $1,300 a year and a lifetime total of $44,000, new research reveals. That means that their out-of-pocket expenses are nearly four times higher compared to people without the inherited blood disorder, the new study found. “Identifying ways to reduce the burden…  read on >  read on >

If you have both asthma and seasonal allergies, there are ways to reduce the impacts of that double whammy, an expert says. People with asthma, a chronic lung condition, should try to control or prevent allergic outbreaks, said Dr. Miranda Curtiss, an assistant professor at the University of Alabama at Birmingham School of Medicine. Nasal…  read on >  read on >